A Review of the Effects of Nicotine on Schizophrenia and Antipsychotic Medications
- 1 October 1999
- journal article
- review article
- Published by American Psychiatric Association Publishing in Psychiatric Services
- Vol. 50 (10) , 1346-1350
Abstract
Research on the impact of nicotine on schizophrenia and antipsychotic medications was reviewed to determine ways to improve treatment planning for patients with schizophrenia who smoke and to evaluate smoking cessation programs for this population. All major research databases were searched. The review focuses on reports published since 1990. Smoking improves processing of auditory stimuli (sensory gating) by patients with schizophrenia and may lessen negative symptoms by increasing dopamine in the nucleus accumbens and the prefrontal and frontal cortex. Use of traditional antipsychotics may result in patients' smoking more, whereas patients taking atypical antipsychotics may smoke less. Patients who smoke metabolize antipsychotics faster than nonsmoking patients. Smoking cessation programs for outpatients with schizophrenia report a success rate of about 12 percent after six months. No studies of cessation programs for chronically ill inpatients with schizophrenia have been published. Several hospitals have implemented smoking bans with equivocal results. Nicotine affects both schizophrenia and antipsychotic medications. Neurobiological and psychosocial factors reinforce the high use of nicotine by patients with schizophreniaKeywords
This publication has 38 references indexed in Scilit:
- Haloperidol increases smoking in patients with schizophreniaPsychopharmacology, 1995
- Nicotinic potentiation of glutamatergic synapses in the prefrontal cortex: New insight into the analysis of the role of nicotinic receptors in cognitive functionsDrug Development Research, 1994
- Smoking and Major DepressionArchives of General Psychiatry, 1993
- Nicotine Dependence and Major DepressionArchives of General Psychiatry, 1993
- A clinical approach to help psychiatric patients with smoking cessationPsychiatric Quarterly, 1992
- Nicotine Dependence, Major Depression, and Anxiety in Young AdultsArchives of General Psychiatry, 1991
- Effects of amperozide in schizophreniaPsychopharmacology, 1991
- Depression and the dynamics of smoking. A national perspectiveJAMA, 1990
- Hypofrontality and cognitive impairment in schizophrenia: Dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain functionBiological Psychiatry, 1990
- Physiological Dysfunction of Dorsolateral Prefrontal Cortex in SchizophreniaArchives of General Psychiatry, 1988